Tweet
it's a drug that acts as a CRTH2 antagonist.... CRTH2 receptor is what we should be targeting to reduce levels of PGD2.
That drug is probably the most efficient at doing that, although it's still in Phase 2 and it's targeted for asthma/allergy patients....
That drug is probably the most efficient at doing that, although it's still in Phase 2 and it's targeted for asthma/allergy patients....